Persistence Market Research Company
Customize Now Get FREE Sample

Vulvar and Vaginal Atrophy Therapy Market Size, Share, and Growth Forecast, 2025 - 2032

Vulvar and Vaginal Atrophy Therapy Market by Therapy Type (Hormonal Therapy, Non-Hormonal Therapy, Topical Treatments, Systemic Treatments), Administration Route (Topical, Oral, Intravaginal, Transdermal), Formulation Type (Creams & Ointments, Pills & Capsules, Gels & Tablets, Others), End-use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), and Regional Analysis for 2025 - 2032

ID: PMRREP32923| 196 Pages | 4 Sep 2025 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Vulvar and Vaginal Atrophy Therapy Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. COVID-19 Impact Analysis
    4. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Value Chain Analysis
    2. Key Market Players
    3. Regulatory Landscape
    4. PESTLE Analysis
    5. Porter’s Five Force Analysis
    6. Consumer Behavior Analysis
  4. Price Trend Analysis, 2019 - 2032
    1. Key Factors Impacting Product and Services Prices
    2. Pricing Analysis, By Therapy Type
    3. Regional Prices and Product and Services Preferences
  5. Global Vulvar and Vaginal Atrophy Therapy Market Outlook
    1. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
    2. Global Vulvar and Vaginal Atrophy Therapy Market Outlook: Therapy Type
      1. Historical Market Size (US$ Bn) Analysis, By Therapy Type, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Therapy Type, 2025-2032
        1. Hormonal Therapy
        2. Non-Hormonal Therapy
        3. Topical Treatments
        4. Systemic Treatments
        5. Others
      3. Market Attractiveness Analysis: Therapy Type
    3. Global Vulvar and Vaginal Atrophy Therapy Market Outlook: Administration Route
      1. Historical Market Size (US$ Bn) Analysis, By Administration Route, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Administration Route, 2025-2032
        1. Topical
        2. Intravaginal
        3. Transdermal
        4. Oral
        5. Pouches
      3. Market Attractiveness Analysis: Administration Route
    4. Global Vulvar and Vaginal Atrophy Therapy Market Outlook: Formulation Type
      1. Historical Market Size (US$ Bn) Analysis, By Formulation Type, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Formulation Type, 2025-2032
        1. Creams & Ointments
        2. Pills & Capsules
        3. Gels & Tablets
        4. Others
      3. Market Attractiveness Analysis: Formulation Type
    5. Global Vulvar and Vaginal Atrophy Therapy Market Outlook: End-use
      1. Historical Market Size (US$ Bn) Analysis, By End-use, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Specialty Clinics
        4. Others
      3. Market Attractiveness Analysis: End-use
  6. Global Vulvar and Vaginal Atrophy Therapy Market Outlook: Region
    1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
    2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
      1. North America
      2. Latin America
      3. Europe
      4. East Asia
      5. South Asia and Oceania
      6. Middle East & Africa
    3. Market Attractiveness Analysis: Region
  7. North America Vulvar and Vaginal Atrophy Therapy Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Therapy Type
      3. By Administration Route
      4. By Formulation Type
      5. By End-use
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. U.S.
      2. Canada
    3. Market Size (US$ Bn) Analysis and Forecast, By Therapy Type, 2025-2032
      1. Hormonal Therapy
      2. Non-Hormonal Therapy
      3. Topical Treatments
      4. Systemic Treatments
      5. Others
    4. Market Size (US$ Bn) Analysis and Forecast, By Administration Route, 2025-2032
      1. Topical
      2. Intravaginal
      3. Transdermal
      4. Oral
      5. Pouches
    5. Market Size (US$ Bn) Analysis and Forecast, By Formulation Type, 2025-2032
      1. Creams & Ointments
      2. Pills & Capsules
      3. Gels & Tablets
      4. Others
    6. Global Vulvar and Vaginal Atrophy Therapy Market Outlook: End-use
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Specialty Clinics
      4. Others
  8. Europe Vulvar and Vaginal Atrophy Therapy Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Therapy Type
      3. By Administration Route
      4. By Formulation Type
      5. By End-use
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    3. Market Size (US$ Bn) Analysis and Forecast, By Therapy Type, 2025-2032
      1. Hormonal Therapy
      2. Non-Hormonal Therapy
      3. Topical Treatments
      4. Systemic Treatments
      5. Others
    4. Market Size (US$ Bn) Analysis and Forecast, By Administration Route, 2025-2032
      1. Topical
      2. Intravaginal
      3. Transdermal
      4. Oral
      5. Pouches
    5. Market Size (US$ Bn) Analysis and Forecast, By Formulation Type, 2025-2032
      1. Creams & Ointments
      2. Pills & Capsules
      3. Gels & Tablets
      4. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End-Use, 2025-2032
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Specialty Clinics
      4. Others
    7. Market Attractiveness Analysis
  9. East Asia Vulvar and Vaginal Atrophy Therapy Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Therapy Type
      3. By Administration Route
      4. By Formulation Type
      5. By End-use
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. China
      2. Japan
      3. South Korea
    3. Market Size (US$ Bn) Analysis and Forecast, By Therapy Type, 2025-2032
      1. Hormonal Therapy
      2. Non-Hormonal Therapy
      3. Topical Treatments
      4. Systemic Treatments
      5. Others
    4. Market Size (US$ Bn) Analysis and Forecast, By Administration Route, 2025-2032
      1. Topical
      2. Intravaginal
      3. Transdermal
      4. Oral
      5. Pouches
    5. Market Size (US$ Bn) Analysis and Forecast, By Formulation Type, 2025-2032
      1. Creams & Ointments
      2. Pills & Capsules
      3. Gels & Tablets
      4. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End-Use, 2025-2032
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Specialty Clinics
      4. Others
    7. Market Attractiveness Analysis
  10. South Asia & Oceania Vulvar and Vaginal Atrophy Therapy Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Therapy Type
      3. By Administration Route
      4. By Formulation Type
      5. By End-use
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. India
      2. Indonesia
      3. Thailand
      4. Singapore
      5. ANZ
      6. Rest of South Asia & Oceania
    3. Market Size (US$ Bn) Analysis and Forecast, By Therapy Type, 2025-2032
      1. Hormonal Therapy
      2. Non-Hormonal Therapy
      3. Topical Treatments
      4. Systemic Treatments
      5. Others
    4. Market Size (US$ Bn) Analysis and Forecast, By Administration Route, 2025-2032
      1. Topical
      2. Intravaginal
      3. Transdermal
      4. Oral
      5. Pouches
    5. Market Size (US$ Bn) Analysis and Forecast, By Formulation Type, 2025-2032
      1. Creams & Ointments
      2. Pills & Capsules
      3. Gels & Tablets
      4. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Specialty Clinics
      4. Others
    7. Market Attractiveness Analysis
  11. Latin America Vulvar and Vaginal Atrophy Therapy Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Therapy Type
      3. By Administration Route
      4. By Formulation Type
      5. By End-use
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    3. Market Size (US$ Bn) Analysis and Forecast, By Therapy Type, 2025-2032
      1. Hormonal Therapy
      2. Non-Hormonal Therapy
      3. Topical Treatments
      4. Systemic Treatments
      5. Others
    4. Market Size (US$ Bn) Analysis and Forecast, By Administration Route, 2025-2032
      1. Topical
      2. Intravaginal
      3. Transdermal
      4. Oral
      5. Pouches
    5. Market Size (US$ Bn) Analysis and Forecast, By Formulation Type, 2025-2032
      1. Creams & Ointments
      2. Pills & Capsules
      3. Gels & Tablets
      4. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Specialty Clinics
      4. Others
    7. Market Attractiveness Analysis
  12. Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Therapy Type
      3. By Administration Route
      4. By Formulation Type
      5. By End-use
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    3. Market Size (US$ Bn) Analysis and Forecast, By Therapy Type, 2025-2032
      1. Hormonal Therapy
      2. Non-Hormonal Therapy
      3. Topical Treatments
      4. Systemic Treatments
      5. Others
    4. Market Size (US$ Bn) Analysis and Forecast, By Administration Route, 2025-2032
      1. Topical
      2. Intravaginal
      3. Transdermal
      4. Oral
      5. Pouches
    5. Market Size (US$ Bn) Analysis and Forecast, By Formulation Type, 2025-2032
      1. Creams & Ointments
      2. Pills & Capsules
      3. Gels & Tablets
      4. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Specialty Clinics
      4. Others
    7. Market Attractiveness Analysis
  13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Estelle Therapeutics
        1. Overview
        2. Segments and Therapy Type
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Eli Lilly
      3. Sanofi
      4. Allergan
      5. TheraNova
      6. Amgen
      7. Bayer
      8. Pfizer
      9. Astellas Pharma
      10. HRT Solutions
      11. Ferring Pharmaceuticals
      12. GSK
      13. AbbVie
      14. Novartis
      15. MediSprout
      16. Other
  14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate